4.7 Article

Author Response: Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis

Ryan L. Davis et al.

Summary: Comprehensive bigenomic sequencing accurately detects causative genetic variants in affected mitochondrial disease patients, providing precise diagnosis, personalized treatment options, and information on genetic transmission risk.

NEUROLOGY (2022)

Article Medicine, General & Internal

Late onset AMACR deficiency with metabolic stroke-like episodes and seizures

Matthew J. Tanti et al.

Summary: AMACR deficiency is a rare peroxisomal disorder that causes pristanic acid accumulation. We presented a case of a female patient in her seventies who experienced dysphasia, headache, and sensory disturbance, along with unusual brain changes seen on MRI. After eight years, she developed a febrile encephalopathy with hemispheric dysfunction, focal convulsive seizures, and coma. Whole genome sequencing finally revealed the diagnosis of AMACR deficiency, with highly elevated pristanic acid levels.

BMJ CASE REPORTS (2022)

Article Medicine, General & Internal

Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study

Katherine R. Schon et al.

Summary: Whole genome sequencing is a useful diagnostic test in patients with suspected mitochondrial disorders, providing a definite or probable genetic diagnosis in 31% of patients, with the majority of diagnoses being non-mitochondrial disorders.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Clinical Neurology

The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease

Eleanor J. Baldwin et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)